Roth Capital Comments on Ontrak, Inc.’s FY2028 Earnings (NASDAQ:OTRK)

Ontrak, Inc. (NASDAQ:OTRK) – Analysts at Roth Capital issued their FY2028 earnings per share (EPS) estimates for shares of Ontrak in a research note issued to investors on Tuesday, April 16th. Roth Capital analyst J. Aschoff anticipates that the company will post earnings of $0.12 per share for the year. The consensus estimate for Ontrak’s current full-year earnings is ($0.34) per share.

Ontrak Price Performance

NASDAQ:OTRK opened at $0.25 on Friday. Ontrak has a 12-month low of $0.14 and a 12-month high of $4.08. The firm has a market capitalization of $6.96 million, a P/E ratio of -0.04 and a beta of 2.43. The business has a 50 day simple moving average of $0.28 and a 200 day simple moving average of $0.45.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Two Sigma Investments LP boosted its position in Ontrak by 119.9% during the 1st quarter. Two Sigma Investments LP now owns 51,600 shares of the company’s stock worth $27,000 after acquiring an additional 28,131 shares during the period. B. Riley Wealth Advisors Inc. acquired a new position in Ontrak during the 3rd quarter worth $34,000. Renaissance Technologies LLC acquired a new position in Ontrak during the 2nd quarter worth $35,000. Charles Schwab Investment Management Inc. boosted its position in Ontrak by 51.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 29,007 shares of the company’s stock worth $66,000 after acquiring an additional 9,895 shares during the period. Finally, XTX Topco Ltd boosted its position in Ontrak by 273.2% during the 1st quarter. XTX Topco Ltd now owns 50,431 shares of the company’s stock worth $114,000 after acquiring an additional 36,918 shares during the period. Institutional investors and hedge funds own 12.95% of the company’s stock.

About Ontrak

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.